| | | | | | | | | | |
|
|
| Dockets Entered
On October 24, 2003
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1976N-0052N
|
| OTC Nasal Decongestants
|
|
|
| 1981N-0033A
|
| Oral Health Care Drug Product; Oral Antiseptic Drug Products
|
|
|
| 1995N-0304
|
| Ephedrine Alkaloids: Reports of Adverse Events; Availability
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
| 1998P-0610
|
| Convert Allegra/Allegra-D,Claritin/Claritin-D,Zyrtec to OTC
|
|
|
| 1999P-1340
|
| Declared Eternity eau de Parfum Misbranded
|
|
|
| 1999P-2630
|
| Establish a Daily Value for "added sugars"
|
|
|
| 2000N-1484
|
| Safety Reporting Requirements Human Drug/Biological Products
|
|
|
| 2001P-0230
|
| Domestic Marketing & Importation of Transgenic Fish
|
|
|
| 2002N-0276
|
| Bioterrorism Preparedness;Registration of Food Facilities
|
|
|
| 2002N-0278
|
| Bioterrorism; Prior Notice of Imported Food Shipments
|
|
|
| 2002P-0163
|
| Expedite Over-the-Counter Approval for Desloratidine
|
|
|
| 2002P-0168
|
| Request better product labeling of sports & energy beverages
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
| 2002P-0505
|
| Labeling nuts & eligible nut containing products reduce risk
|
|
|
| 2003D-0386
|
| Guidance for Industry on Formal Dispute Resolution: Scientific and Technical Issues Related to Pharmaceutical CGMP
|
|
|
| 2003N-0211
|
| Revisions to Labeling and Storage Requirements for Blood and Blood Components, Including Source Plasma
|
|
|
| 2003N-0324
|
| Certain Antibiotic New Animal Drug Products and Use Combinations Subject to Listings in Sections 510.515 and/or 558.15; Drugs Efficacy Study Implementation; Notice of Opportunity for Hearing
|
|
|
|
| 2003N-0338
|
| Obesity
|
|
|
| 2003N-0361
|
| Anti-Counterfeit Drug Initiative
|
|
|
| 2003P-0270
|
| Prohibit False and Misleading Labeling
|
|
|
| 2003P-0313
|
| Canned Tuna Deviating From Identity Standard; Temporary Permit for Market Testing
|
|
|
| 2003P-0408
|
| Request for Immediate Withdrawal of Final Approval of Syntheon's NDA No. 21-299 for Asimia (Paroxetine Mesylate) 10 mg, 20 mg, 30 mg and 40 mg Tablets
|
|
|
| 2003V-0430
|
| Laser Light Show
|
|
|
| 1976N-0052N
|
| OTC Nasal Decongestants
|
|
|
| EMC 131
|
| K. Todd
|
| Vol #:
|
| 77
|
|
|
| 1981N-0033A
|
| Oral Health Care Drug Product; Oral Antiseptic Drug Products
|
|
|
| LET
3
|
| HFD-001 to Olsson, Frank and Weeda, PC
|
| Vol #:
|
| 1
|
|
|
| 1995N-0304
|
| Ephedrine Alkaloids: Reports of Adverse Events; Availability
|
|
|
| EMC 929
|
| J. Stumme
|
| Vol #:
|
| 375
|
|
|
| EMC 930
|
| No signature
|
| Vol #:
|
| 375
|
|
|
| EMC 931
|
| J.G. Murphy
|
| Vol #:
|
| 375
|
|
| | | | | | | | |
|
|
| EMC 3830
|
| Mary Ashley White
|
| Vol #:
|
| 281
|
|
|
| EMC 3831
|
| Amie Benedetto
|
| Vol #:
|
| 281
|
|
|
| EMC 3832
|
| Kathy Andrew
|
| Vol #:
|
| 281
|
|
|
| EMC 3833
|
| Michele A. Valli
|
| Vol #:
|
| 281
|
|
|
| EMC 3834
|
| Sally Ackerman
|
| Vol #:
|
| 281
|
|
|
| EMC 3835
|
| Meredith Erickson
|
| Vol #:
|
| 281
|
|
|
| EMC 3836
|
| Rebecca
|
| Vol #:
|
| 281
|
|
|
| EMC 3837
|
| Joviann Mech
|
| Vol #:
|
| 281
|
|
|
| EMC 3838
|
| Alice Solilman
|
| Vol #:
|
| 281
|
|
|
| EMC 3839
|
| Alice Soliman
|
| Vol #:
|
| 281
|
|
|
| EMC 3840
|
| Aslan Brooke
|
| Vol #:
|
| 281
|
|
|
| EMC 3841
|
| Vicki Castrejon
|
| Vol #:
|
| 281
|
|
|
| EMC 3842
|
| Charlotta Beavers
|
| Vol #:
|
| 281
|
|
|
| EMC 3843
|
| Kandi Jones
|
| Vol #:
|
| 281
|
|
|
| 1998P-0610
|
| Convert Allegra/Allegra-D,Claritin/Claritin-D,Zyrtec to OTC
|
|
|
| EMC
94
|
| Citizen Outreach
|
| Vol #:
|
| 5
|
|
|
| EMC
95
|
| Citizen Outreach
|
| Vol #:
|
| 5
|
|
|
| EMC
96
|
| National Consumers League
|
| Vol #:
|
| 5
|
|
|
| 1999P-1340
|
| Declared Eternity eau de Parfum Misbranded
|
|
|
| EMC 476
|
| Chris
|
| Vol #:
|
| 21
|
|
|
| EMC 477
|
| Kelly Villalobos
|
| Vol #:
|
| 21
|
|
|
| 1999P-2630
|
| Establish a Daily Value for "added sugars"
|
|
|
| EMC 566
|
| Ronit Feinglass
|
| Vol #:
|
| 32
|
|
|
| 2000N-1484
|
| Safety Reporting Requirements Human Drug/Biological Products
|
|
|
| EMC
57
|
| Applied Research Ethics National Assn (ARENA)
|
| Vol #:
|
| 5
|
|
|
| EMC 58
|
| Lu Hubert,MS,MT(ASCP)BB
|
| Vol #:
|
| 5
|
|
|
| EMC 59
|
| Kitty Guild, M.T.
|
| Vol #:
|
| 5
|
|
|
| EMC
60
|
| Fujisawa Healthcare, Inc.
|
| Vol #:
|
| 5
|
|
|
| EMC
61
Attachment 1,
2
|
| MSSO Products & Services
|
| Vol #:
|
| 5
|
|
|
| EMC
62
|
| AIDS Treatment Activist Coalition (ATAC)
|
| Vol #:
|
| 5
|
|
|
| EMC 63
|
| Alain J. Marengo-Rowe, MD
|
| Vol #:
|
| 5
|
|
|
| EMC
64
|
| Allina Medical Laboratories
|
| Vol #:
|
| 5
|
|
|
| EMC
65
|
| Berlex Laboratories, Inc.
|
| Vol #:
|
| 5
|
|
|
| EMC 66
|
| Janice M. Sigmon
|
| Vol #:
|
| 5
|
|
| | | | | | | | |
|
|
| EMC
67
|
| Amgen, Inc.
|
| Vol #:
|
| 5
|
|
|
| 2001P-0230
|
| Domestic Marketing & Importation of Transgenic Fish
|
|
|
| EMC 3144
|
| Alison Payne
|
| Vol #:
|
| 252
|
|
|
| 2002N-0276
|
| Bioterrorism Preparedness;Registration of Food Facilities
|
|
|
| EMC 97
|
| No signature
|
| Vol #:
|
| 15
|
|
|
| EMC
98
|
| Honorable Russell D. Feingold
|
| Vol #:
|
| 15
|
|
|
| EMC
99
|
| Honorable Russell D. Feingold
|
| Vol #:
|
| 15
|
|
|
| 2002N-0278
|
| Bioterrorism; Prior Notice of Imported Food Shipments
|
|
|
| EMC
120
|
| Honorable Russell D. Feingold
|
| Vol #:
|
| 17
|
|
|
| EMC
121
|
| Honorable Russell D. Feingold
|
| Vol #:
|
| 17
|
|
|
| 2002P-0163
|
| Expedite Over-the-Counter Approval for Desloratidine
|
|
|
| EMC
5
|
| National Consumers League
|
| Vol #:
|
| 1
|
|
|
| 2002P-0168
|
| Request better product labeling of sports & energy beverages
|
|
|
| EMC
3
|
| Citizen Outreach
|
| Vol #:
|
| 1
|
|
|
| EMC
4
|
| Citizen Outreach
|
| Vol #:
|
| 1
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
| EMC 283
|
| Betty Martini
|
| Vol #:
|
| 5
|
|
|
| EMC 284
|
| Betty Martini
|
| Vol #:
|
| 5
|
|
|
| EMC 285
|
| Betty Martini
|
| Vol #:
|
| 5
|
|
|
| 2002P-0505
|
| Labeling nuts & eligible nut containing products reduce risk
|
|
|
| EMC
1
|
| Grocery Manufacturers of America (GMA)
|
| Vol #:
|
| 4
|
|
|
| 2003D-0386
|
| Guidance for Industry on Formal Dispute Resolution: Scientific and Technical Issues Related to Pharmaceutical CGMP
|
|
|
| C
1
|
| The Williamsburg Group
|
| Vol #:
|
| 1
|
|
|
| 2003N-0211
|
| Revisions to Labeling and Storage Requirements for Blood and Blood Components, Including Source Plasma
|
|
|
| C
5
|
| Henry County Health Center
|
| Vol #:
|
| 1
|
|
|
| 2003N-0324
|
| Certain Antibiotic New Animal Drug Products and Use Combinations Subject to Listings in Sections 510.515 and/or 558.15; Drugs Efficacy Study Implementation; Notice of Opportunity for Hearing
|
|
|
|
|
|
| SF
1
|
| GCF-1
|
| Vol #:
|
| 1
|
|
|
| 2003N-0338
|
| Obesity
|
|
|
| C
5
|
| American Obesity Assn (AOA)
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
|
| 2003N-0361
|
| Anti-Counterfeit Drug Initiative
|
|
|
| C 3
|
| Ruth Schiedermayer
|
| Vol #:
|
| 3
|
|
|
| C
4
|
| Closure Manufacturers Assn (CMA)
|
| Vol #:
|
| 3
|
|
|
| 2003P-0270
|
| Prohibit False and Misleading Labeling
|
|
|
| C 32
|
| Lisa Barton
|
| Vol #:
|
| 5
|
|
|
| C 33
|
| Rita A. Campbell
|
| Vol #:
|
| 5
|
|
|
| C 34
|
| Jane Kramer
|
| Vol #:
|
| 5
|
|
|
| 2003P-0313
|
| Canned Tuna Deviating From Identity Standard; Temporary Permit for Market Testing
|
|
|
| LET
3
|
| HFS-811 to Bumble Bee Seafoods, Inc
|
| Vol #:
|
| 1
|
|
|
| 2003P-0408
|
| Request for Immediate Withdrawal of Final Approval of Syntheon's NDA No. 21-299 for Asimia (Paroxetine Mesylate) 10 mg, 20 mg, 30 mg and 40 mg Tablets
|
|
|
| PDN
1
|
| HFD-1 toTorPharm, Inc.
|
| Vol #:
|
| 1
|
|
|
| 2003V-0430
|
| Laser Light Show
|
|
|
| VRA
1
|
| HFZ-300 to Laser Magic Productions
|
| Vol #:
|
| 1
|
|